Bladder Cancer Academy 2018 Selected Summaries
- PMID: 29942200
- PMCID: PMC6003302
- DOI: 10.3909/riu02001BCA
Bladder Cancer Academy 2018 Selected Summaries
Keywords: Immunotherapy; Intravesical chemotherapy; Renal masses; Transurethral resection of a bladder tumor (TURBT); Trimodal therapy (TMT); Urinary biomarkers.
References
-
- Urine tumor markers in bladder cancer diagnosis: overview of urine tumor markers, genetic aberrations in bladder cancer, fluorescence in situ hybridization. Medscape website. https://emedicine.medscape.com/article/1953022-overview. Accessed March 18, 2018.
-
- Fradet Y, Lockhard C. Performance characteristics of a new monoclonal antibody test for bladder cancer: ImmunoCyt™. Can J Urol. 1997;4:400–405. - PubMed
-
- Gayed BA, Seideman C, Lotan Y. Cost-effectiveness of fluorescence in situ hybridization in patients with atypical cytology for the detection of urothelial carcinoma. J Urol. 2013;190:1181–1186. - PubMed
LinkOut - more resources
Full Text Sources